Healthcare

Pharmaceutical Contract Manufacturing And Research Services Market Size Breaks US$ 376.8 billion by 2030

The global Pharmaceutical Contract Manufacturing And Research Services market size is expected to be worth around US$ 376.8 billion by 2030, according to a new report by Vision Research Reports.

Pharmaceutical Contract Manufacturing And Research Services Market (By Service: Manufacturing, Research) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/38316

Report Coverage Details
Market Size US$ 376.8 billion by 2030
Growth Rate CAGR of 10.75% From 2021 to 2030
Base year 2020
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segments Covered Service

Growth Factors

The rising investments in R&D, increasing demand for generics, and the growing aging population with various chronic diseases are responsible for market growth.

The focus of large pharmaceutical companies to strategically engage with a small number of preferred providers is a meaningful solution from procurement-based outsourcing. This was one of the many business traits that this service industry has become accustomed to. Service providers that hold the potential of providing cost and quality advantages are set to make inroads and grow at a tremendous pace in the forecast period.

However, drug manufacturers are increasing their investments with respect to production capabilities. This may limit the potential growth of contract manufacturing services to traditional customers, thereby hampering industrial growth. However, the COVID-19 pandemic has provided new opportunities for pharmaceutical contract manufacturing and research services.

Key Players

  • Catalent
  • Pharmaceutical Product Development LLC
  • AbbVie
  • Baxter BioPharma Solutions
  • Patheon
  • Grifols International, S.A.
  • Dalton Pharma Services
  • Boehringer Ingelheim Biopharmaceuticals GmbH
  • Lonza AG

Market Segmentation

  • Service Outlook
    • Manufacturing
      • API/Bulk Drugs
      • Advanced Drug Delivery Formulations Packaging
      • Packaging
      • Finished Dose Formulations
        • Solid Formulations
        • Liquid Formulations
        • Semi-solid Formulations
    • Research
      • Oncology
      • Vaccines
      • Inflammation & Immunology
      • Cardiology
      • Neuroscience
      • Others
  • Regional Outlook
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • France
    • Asia Pacific
      • India
      • China
    • Latin America
      • Brazil
      • Mexico
      • Colombia
      • Argentina
      • Chile
      • Venezuela
    • Middle East and Africa (MEA)
      • South Africa

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Pharmaceutical Contract Manufacturing And Research Services Market, By Service

7.1.  Pharmaceutical Contract Manufacturing And Research Services Market, by Service, 2020-2030

7.1.1.    Manufacturing

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Research

7.1.2.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Pharmaceutical Contract Manufacturing And Research Services Market, Regional Estimates and Trend Forecast

8.1.  North America

8.1.1.    Market Revenue and Forecast, by Service (2016-2030)

8.1.2.    U.S.

8.1.3.    Rest of North America

8.1.3.1.        Market Revenue and Forecast, by Service (2016-2030)

8.2.  Europe

8.2.1.    Market Revenue and Forecast, by Service (2016-2030)

8.2.2.    UK

8.2.2.1.        Market Revenue and Forecast, by Service (2016-2030)

8.2.3.    France

8.2.3.1.        Market Revenue and Forecast, by Service (2016-2030)

8.2.4.    Rest of Europe

8.2.4.1.        Market Revenue and Forecast, by Service (2016-2030)

8.3.  APAC

8.3.1.    Market Revenue and Forecast, by Service (2016-2030)

8.3.2.    India

8.3.2.1.        Market Revenue and Forecast, by Service (2016-2030)

8.3.3.    China

8.3.3.1.        Market Revenue and Forecast, by Service (2016-2030)

8.3.4.    Japan

8.3.4.1.        Market Revenue and Forecast, by Service (2016-2030)

8.3.5.    Rest of APAC

8.3.5.1.        Market Revenue and Forecast, by Service (2016-2030)

8.4.  MEA

8.4.1.    Market Revenue and Forecast, by Service (2016-2030)

8.4.2.    GCC

8.4.2.1.        Market Revenue and Forecast, by Service (2016-2030)

8.4.3.    North Africa

8.4.3.1.        Market Revenue and Forecast, by Service (2016-2030)

8.4.4.    South Africa

8.4.4.1.        Market Revenue and Forecast, by Service (2016-2030)

8.4.5.    Rest of MEA

8.4.5.1.        Market Revenue and Forecast, by Service (2016-2030)

8.5.  Latin America

8.5.1.    Market Revenue and Forecast, by Service (2016-2030)

8.5.2.    Brazil

8.5.2.1.        Market Revenue and Forecast, by Service (2016-2030)

8.5.3.    Rest of LATAM

8.5.3.1.        Market Revenue and Forecast, by Service (2016-2030)

Chapter 9.    Company Profiles

9.1.  Company 1

9.1.1.    Company Overview

9.1.2.    Product Offerings

9.1.3.    Financial Performance

9.1.4.    Recent Initiatives

9.2.  Company 2

9.2.1.    Company Overview

9.2.2.    Product Offerings

9.2.3.    Financial Performance

9.2.4.    Recent Initiatives

9.3.  Company 3

9.3.1.    Company Overview

9.3.2.    Product Offerings

9.3.3.    Financial Performance

9.3.4.    Recent Initiatives

9.4.  Company 4

9.4.1.    Company Overview

9.4.2.    Product Offerings

9.4.3.    Financial Performance

9.4.4.    Recent Initiatives

9.5.  Company 5

9.5.1.    Company Overview

9.5.2.    Product Offerings

9.5.3.    Financial Performance

9.5.4.    Recent Initiatives

9.6.  Company 6

9.6.1.    Company Overview

9.6.2.    Product Offerings

9.6.3.    Financial Performance

9.6.4.    Recent Initiatives

9.7.  Company 7

9.7.1.    Company Overview

9.7.2.    Product Offerings

9.7.3.    Financial Performance

9.7.4.    Recent Initiatives

9.8.  Company 8

9.8.1.    Company Overview

9.8.2.    Product Offerings

9.8.3.    Financial Performance

9.8.4.    Recent Initiatives

Chapter 10.  Research Methodology

10.1.              Primary Research

10.2.              Secondary Research

10.3.              Assumptions

Chapter 11.  Appendix

11.1.              About Us

Glossary of Terms

Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38316

About Us: Our team of skilled and experienced analysts specializes in troubleshooting problems faced by our clients. For comprehensive summary of our services and market research requirements for Global industry.

Contact Us:

call: +1 9197 992 333

Vision Research Report

Any Assistance, Email – sales@visionresearchreports.com

Show More

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

Related Articles

Back to top button